Back to Agenda
Medical Devices in Clinical Trials
Session Chair(s)
Isabelle Clamou
Policy Officer, DG SANTE Unit D2, European Commission, Belgium
Olga Tkachenko, PHD
Policy Officer, European Commission, Belgium
This session will present the COMBINE project on the interface between the EU regulations on clinical trials, in vitro diagnostics and medical devices. Combined studies can be understood as studies that involve the simultaneous investigation of a medicinal product, an IVD and/or medical device. The COMBINE project aims to analyse the root causes of the challenges encountered by sponsors in conducting combined studies and to identify possible solutions to these challenges. The project involves representatives of competent authorities, the European Commission, medical research ethics committees, the European Medicines Agency, and relevant stakeholders from both the medicinal product and the medical device sectors. This is a first of kind collaboration across the clinical trials and medical devices sectors looking into the challenges faced by sponsors and authorities in the assessment and authorisation of combined studies.
Speaker(s)
Olga Tkachenko, PHD
Policy Officer, European Commission, Belgium
COMBINE Project: Background and Scope
Lucia D'Apote, DRSC, RAC
Executive Director Global Regulatory Policy, Amgen, Switzerland
COMBINE Project : Issue list (1)
Jana Russo
Manager Medical Devices, MedTech Europe, Belgium
COMBINE Project: Issue list (2)
Gearoid O'Connor, MD, MSC
Medical Officer, Medical Devices, HPRA, Ireland
COMBINE Project: Mapping of the EU landscape
Ditte Zerlang Andersen, PHD, MSC
Senior Strategy Project Lead, Danish Medicines Agency (DKMA), Denmark
COMBINE Project: Proposals for Solutions and Next Steps
Marianne Carson
Senior Advisor, University of Oslo (UiO), Norway
Panelist
Have an account?